We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.
 

Search Results

Blog Post

Public Comment on FDA Draft Biosimilars Guidances

29 February 2012

Thoughts on the U.S. Food and Drug Administration’s recently issued biosimilar guidance documents?  The time to act is now.  As described in our earlier post , FDA must provide the public...

Topic Center

LimeGreen IP News

Detailed discussions on recent case law and business critical IP trends from around the globe.

LimeGreen IP News
Loading data